Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation

Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

Lin Zhang, José R. Conejo-García, Dionyssios Katsaros et al. · New England Journal of Medicine · 2003 · 3.4K citations · Full text

A role for CD95 ligand in preventing graft rejection

Donald Bellgrau, Daniel P. Gold, Helena Selawry et al. · Nature · 1995 · 1.2K citations

Cell Therapy, Transplantation, Immunology +8

Expression of the Fas ligand in cells of T cell lineage.

Takashi Suda, Tetsuya Okazaki, Yuki Naito et al. · The Journal of Immunology · 1995 · 650 citations

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

Philippe Saas, Paul R. Walker, Michael Hahne et al. · Journal of Clinical Investigation · 1997 · 404 citations · Full text

Immunology, Maintaining Immune Privilege, Cell Death +20

Human lung carcinomas express Fas ligand.

G A Niehans, Thomas Brunner, Sandra Frizelle et al. · PubMed · 1997 · 396 citations

Tumor Biology, Cancer Immunosurveillance, Medicine +14